101 related articles for article (PubMed ID: 11535810)
1. An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease.
Mochizuki H; Hayakawa H; Migita M; Shibata M; Tanaka R; Suzuki A; Shimo-Nakanishi Y; Urabe T; Yamada M; Tamayose K; Shimada T; Miura M; Mizuno Y
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10918-23. PubMed ID: 11535810
[TBL] [Abstract][Full Text] [Related]
2. Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review.
Szwec S; Kapłucha Z; Chamberlain JS; Konieczny P
BioDrugs; 2024 Jan; 38(1):95-119. PubMed ID: 37917377
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson's Disease.
Chang KH; Liu CH; Wang YR; Lo YS; Chang CW; Wu HC; Chen CM
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108258
[TBL] [Abstract][Full Text] [Related]
4. Neurodegenerative Diseases: From Dysproteostasis, Altered Calcium Signalosome to Selective Neuronal Vulnerability to AAV-Mediated Gene Therapy.
Quach TT; Stratton HJ; Khanna R; Mackey-Alfonso S; Deems N; Honnorat J; Meyer K; Duchemin AM
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430666
[TBL] [Abstract][Full Text] [Related]
5. Supramolecular organizing centers at the interface of inflammation and neurodegeneration.
Sušjan-Leite P; Ramuta TŽ; Boršić E; Orehek S; Hafner-Bratkovič I
Front Immunol; 2022; 13():940969. PubMed ID: 35979366
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HDAC increases BDNF expression and promotes neuronal rewiring and functional recovery after brain injury.
Sada N; Fujita Y; Mizuta N; Ueno M; Furukawa T; Yamashita T
Cell Death Dis; 2020 Aug; 11(8):655. PubMed ID: 32811822
[TBL] [Abstract][Full Text] [Related]
7. Increased Expression of Fibronectin Leucine-Rich Transmembrane Protein 3 in the Dorsal Root Ganglion Induces Neuropathic Pain in Rats.
Yamada M; Fujita Y; Hayano Y; Hayakawa H; Baba K; Mochizuki H; Yamashita T
J Neurosci; 2019 Sep; 39(38):7615-7627. PubMed ID: 31346030
[TBL] [Abstract][Full Text] [Related]
8. Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review.
Lang Y; Chu F; Shen D; Zhang W; Zheng C; Zhu J; Cui L
Mediators Inflamm; 2018; 2018():1549549. PubMed ID: 29849483
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease.
Budge KM; Neal ML; Richardson JR; Safadi FF
Mol Neurobiol; 2018 Jun; 55(6):5167-5176. PubMed ID: 28856541
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy targeting mitochondrial pathway in Parkinson's disease.
Choong CJ; Mochizuki H
J Neural Transm (Vienna); 2017 Feb; 124(2):193-207. PubMed ID: 27638713
[TBL] [Abstract][Full Text] [Related]
11. Promotion of mitochondrial biogenesis by necdin protects neurons against mitochondrial insults.
Hasegawa K; Yasuda T; Shiraishi C; Fujiwara K; Przedborski S; Mochizuki H; Yoshikawa K
Nat Commun; 2016 Mar; 7():10943. PubMed ID: 26971449
[TBL] [Abstract][Full Text] [Related]
12. Apaf1 inhibition promotes cell recovery from apoptosis.
Gortat A; Sancho M; Mondragón L; Messeguer À; Pérez-Payá E; Orzáez M
Protein Cell; 2015 Nov; 6(11):833-43. PubMed ID: 26361785
[TBL] [Abstract][Full Text] [Related]
13. Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems.
Amelio I; Landré V; Knight RA; Lisitsa A; Melino G; Antonov AV
Oncotarget; 2015; 6(12):9646-56. PubMed ID: 25991664
[TBL] [Abstract][Full Text] [Related]
14. Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons.
Prakash J; Chouhan S; Yadav SK; Westfall S; Rai SN; Singh SP
Neurochem Res; 2014 Dec; 39(12):2527-36. PubMed ID: 25403619
[TBL] [Abstract][Full Text] [Related]
15. Apaf-1 inhibitors protect from unwanted cell death in in vivo models of kidney ischemia and chemotherapy induced ototoxicity.
Orzáez M; Sancho M; Marchán S; Mondragón L; Montava R; Valero JG; Landeta O; Basañez G; Carbajo RJ; Pineda-Lucena A; Bujons J; Moure A; Messeguer A; Lagunas C; Herrero C; Pérez-Payá E
PLoS One; 2014; 9(10):e110979. PubMed ID: 25330150
[TBL] [Abstract][Full Text] [Related]
16. BAG1 is neuroprotective in in vivo and in vitro models of Parkinson's disease.
Kermer P; Köhn A; Schnieder M; Lingor P; Bähr M; Liman J; Dohm CP
J Mol Neurosci; 2015 Mar; 55(3):587-95. PubMed ID: 25106480
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism.
Prakash J; Yadav SK; Chouhan S; Singh SP
Neurochem Res; 2013 May; 38(5):972-80. PubMed ID: 23430469
[TBL] [Abstract][Full Text] [Related]
18. MPTP mouse models of Parkinson's disease: an update.
Meredith GE; Rademacher DJ
J Parkinsons Dis; 2011; 1(1):19-33. PubMed ID: 23275799
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial biology and Parkinson's disease.
Perier C; Vila M
Cold Spring Harb Perspect Med; 2012 Feb; 2(2):a009332. PubMed ID: 22355801
[TBL] [Abstract][Full Text] [Related]
20. The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration.
Drouin-Ouellet J; Gibrat C; Bousquet M; Calon F; Kriz J; Cicchetti F
J Neuroinflammation; 2011 Oct; 8():137. PubMed ID: 21989292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
